Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptors, especially TLR3 and TLR4, are transmembrane pattern recognition receptors that detect pathogenic molecules and initiate powerful innate immune responses, including the production of interferon beta (IFN-β)[2][4]. TLR3 recognizes double-stranded RNA, mainly of viral origin, and signals exclusively through the TRIF adaptor, leading to IRF3/7 activation and robust IFN-β production[2]. TLR4 recognizes bacterial lipopolysaccharide (LPS) and signals through both MyD88-dependent and TRIF-dependent pathways; the latter is critical for IFN-β induction[1][4]. Modulation of TLR signaling has implications for infectious diseases, cancer, and autoimmune conditions, making TLR3 and TLR4 important therapeutic targets. If structure is required, select Toll-like receptor 3 (TLR3) or Toll-like receptor 4 (TLR4) as the canonical targets mediating IFN-β production[2][4]. The phrase "Toll-like receptors mediating IFN-β production" is not a proper canonical name, but a functional description; the correct structured approach would be to specify the individual TLRs involved in the pathway.
Agonism: Activates receptor to induce IFN-β and other type I interferons for antiviral/immune modulation. Antagonism: Inhibits receptor to suppress excessive immune/inflammatory response (potentially reduce cytokine storm).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 3 and Toll-like receptor 4 (TLR3, TLR4).